Inhibition of the AKT pathway in cholangiocarcinoma by MK2206 reduces cellular viability via induction of apoptosis

被引：0
|
作者：
Jacob M Wilson
Selvi Kunnimalaiyaan
Muthusamy Kunnimalaiyaan
T Clark Gamblin
机构：
[1] Medical College of Wisconsin,Department of Surgery, Division of Surgical Oncology
[2] Medical College of Wisconsin,undefined
[3] Translational and Biomedical Research Center,undefined
来源：
Cancer Cell International | / 15卷
关键词：
Cholangiocarcinoma; MK2206; PI3K/mTOR/AKT; Apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Inhibition of the AKT pathway in cholangiocarcinoma by MK2206 reduces cellular viability via induction of apoptosis
    Wilson, Jacob M.
    Kunnimalaiyaan, Selvi
    Kunnimalaiyaan, Muthusamy
    Gamblin, T. Clark
    CANCER CELL INTERNATIONAL, 2015, 15
  • [2] MK2206 inhibits hepatocellular carcinoma cellular proliferation via induction of apoptosis and cell cycle arrest
    Wilson, J. M.
    Kunnimalaiyaan, S.
    Gamblin, T. C.
    Kunnimalaiyaan, M.
    JOURNAL OF SURGICAL RESEARCH, 2014, 191 (02) : 280 - 285
  • [3] MK2206 Enhances Cisplatin-Induced Cytotoxicity and Apoptosis in Testicular Cancer Through Akt Signaling Pathway Inhibition
    Sun, Dingqi
    Wang, Jinhua
    Zhang, Hui
    Liu, Shuai
    Wei, Peng
    Wang, Haoran
    Xu, Zhen
    Fu, Qiang
    Zhang, Keqin
    TRANSLATIONAL ONCOLOGY, 2020, 13 (07):
  • [4] MK2206 potentiates cisplatin-induced cytotoxicity and apoptosis through an interaction of inactivated Akt signaling pathway
    Sun, Dingqi
    Sawada, Atsuro
    Nakashima, Masakazu
    Kobayashi, Takashi
    Ogawa, Osamu
    Matsui, Yoshiyuki
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2015, 33 (03) : 111.e17 - 111.e26
  • [5] MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway
    Ru-Fang Xiang
    Yan Wang
    Nan Zhang
    Wen-Bin Xu
    Yang Cao
    Jia Tong
    Jun-min Li
    Ying-Li Wu
    Hua Yan
    Cell Death & Disease, 2017, 8 : e2776 - e2776
  • [6] MK2206 enhances cisplatin-induced cytotoxicity and apoptosis in testicular cancer through Akt signaling pathway inhibition (vol 13, 100769, 2020)
    Sun, Dingqi
    Wang, Jinhua
    Zhang, Hui
    Liu, Shuai
    Wei, Peng
    Wang, Haoran
    Xu, Zhen
    Fu, Qiang
    Zhang, Keqin
    TRANSLATIONAL ONCOLOGY, 2022, 18
  • [7] MK2206 enhances the cytocidal effects of bufalin in multiple myeloma by inhibiting the AKT/mTOR pathway
    Xiang, Ru-Fang
    Wang, Yan
    Zhang, Nan
    Xu, Wen-Bin
    Cao, Yang
    Tong, Jia
    Li, Jun-min
    Wu, Ying-Li
    Yan, Hua
    CELL DEATH & DISEASE, 2017, 8 : e2776 - e2776
  • [8] The cytotoxicity and cellular effects of AKT inhibition by MK2206 and PI3-kinase d inhibition by Idelalisib against CLL cells in an in vitro model of the hypoxic microenvironment
    Shen, Yandong
    Best, Giles
    Mulligan, Stephen P.
    Christopherson, Richard
    LEUKEMIA & LYMPHOMA, 2017, 58 : 16 - 17
  • [9] Akt inhibitor MK-2206 reduces pancreatic cancer cell viability and increases the efficacy of gemcitabine
    Wang, Zhanshan
    Luo, Guangtao
    Qiu, Zhengjun
    ONCOLOGY LETTERS, 2020, 19 (03) : 1999 - 2004
  • [10] Dual inhibition of MEK1/2 and AKT by binimetinib and MK2206 induces apoptosis of chronic lymphocytic leukemia cells under conditions that mimic the tumor microenvironment
    Shen, Yandong
    Crassini, Kyle
    Sandhu, Suneet
    Fatima, Narjis
    Christopherson, Richard I.
    Mulligan, Stephen P.
    Best, O. Giles
    LEUKEMIA & LYMPHOMA, 2019, 60 (07) : 1632 - 1643
12345